sever
interstiti
lung
diseas
ild
intract
treatment
affect
korea
everi
spring
sinc
approxim
similar
ild
led
death
sever
pregnant
women
base
result
epidemiolog
studi
anim
studi
korea
center
diseas
control
prevent
kcdc
disclos
disinfect
nebul
humidifi
might
caus
lethal
lung
injuri
disinfect
compos
ethoxyethyl
guanidium
chlorid
pgh
polyhexamethyleneguanidin
phmg
one
cmit
mit
didecyldimethylammonium
chlorid
ddac
report
caus
fatal
lung
injuri
prohibit
use
may
lead
inhal
recent
casecontrol
studi
multicent
intervent
studi
korea
provid
evid
suggest
caus
fatal
ild
appear
humidifi
disinfect
american
thorac
societi
european
respiratori
societi
recent
updat
guidelin
diagnosi
classif
manag
ild
children
interstiti
lung
diseas
child
howev
ild
still
divers
diseas
group
high
mortal
morbid
increas
preval
continu
effort
determin
reliabl
prognost
factor
effect
treatment
increas
understand
pathophysiolog
ild
sever
possibl
prognost
marker
propos
includ
interleukin
matrix
metalloproteinas
mmp
vascular
endotheli
growth
factor
vegf
transform
growth
factor
beta
tgfb
kreb
von
den
repres
inflammatori
fibrot
cytokin
monocyt
chemotact
protein
howev
biomark
establish
standard
manag
patient
ild
current
paradigm
understand
pathophysiolog
ild
involv
chronic
inflamm
repetit
injuri
lung
epitheli
cell
follow
aberr
repair
process
lead
excess
irrevers
lung
fibrosi
process
may
progress
gradual
rapidli
may
ceas
lung
damag
mild
progress
sever
lung
dysfunct
despit
current
medic
advanc
still
unabl
predict
exact
progress
ultim
prognosi
diseas
exist
studi
gener
focus
investig
clinic
characterist
cytokin
singl
time
unabl
determin
factor
reliabl
predict
progress
prognosi
ild
mani
effort
determin
clinic
prognost
factor
humidifi
disinfectantassoci
children
interstiti
lung
diseas
hdchild
ild
progress
rapidli
refractori
treatment
nonsurvivor
wherea
clinic
cours
survivor
tend
highli
favor
disappointingli
initi
clinic
characterist
radiolog
patholog
laboratori
find
significantli
associ
surviv
recent
report
nationwid
intervent
studi
indic
humidifi
disinfect
could
possibl
caus
mention
limit
caus
lack
knowledg
differ
individu
suscept
studi
compar
serial
chang
pulmonari
inflammatori
fibrot
cytokin
survivor
nonsurvivor
evalu
whether
pattern
chang
cytokin
could
use
prognost
marker
also
examin
potenti
correl
chang
use
prognost
cytokin
clinic
indic
radiolog
patholog
laboratori
find
total
children
diagnos
hdchild
includ
patient
report
previou
nationwid
report
enrol
studi
children
admit
sever
children
hospit
februari
may
satisfi
diagnost
criteria
report
previous
briefli
criteria
follow
age
less
year
time
diagnosi
rapid
progress
acut
respiratori
distress
chest
tomograph
ct
find
diffus
centrilobular
groundglass
opac
andor
air
leak
syndrom
pneumothorax
pneumomediastinum
subcutan
emphysema
children
check
expos
humidifi
disinfect
diagnosi
interview
parent
confirm
hdchild
thorough
previou
nationwid
report
serum
sampl
collect
weekli
hospit
admiss
discharg
death
determin
clinic
prognost
factor
collect
inform
regard
patient
demograph
data
laboratori
find
treatment
ct
result
patholog
find
studi
approv
institut
review
board
sever
hospit
seoul
korea
irb
children
underw
thinsect
ct
scan
chest
ct
imag
review
score
two
radiolog
specialist
detail
regard
methodolog
use
radiolog
review
score
provid
onlin
data
supplement
patholog
diagnosi
made
lung
biopsi
obtain
videoassist
thoracoscop
surgeri
patient
biopsi
perform
within
week
admiss
evalu
grade
patholog
find
two
pathologist
review
specimen
detail
method
use
patholog
review
score
provid
onlin
data
supplement
serum
level
follow
measur
enzymelink
immunosorb
assay
accord
manufactur
r
system
minneapoli
mn
instruct
monocyt
chemoattract
periostin
vascular
endotheli
growth
factor
vegf
regul
activ
normal
cell
express
secret
rant
cytokin
granulocyt
macrophagecoloni
stimul
factor
gmcsf
patient
characterist
laboratori
data
ct
result
patholog
find
treatment
compar
survivor
nonsurvivor
group
studi
protocol
indic
serum
sampl
would
collect
weekli
hospit
stay
howev
patient
whose
condit
extrem
unstabl
underw
concurr
blood
sampl
monitor
treatment
serum
sampl
studi
collect
exact
weekli
interv
sinc
clinic
cours
length
hospit
stay
vari
wide
child
child
substanti
quantiti
serum
cytokin
data
miss
account
miss
data
irregular
interv
serial
serum
cytokin
collect
use
gener
linear
mixedeffect
model
compar
slope
chang
serial
serum
cytokin
among
survivor
nonsurvivor
evalu
slope
chang
estim
valu
standard
error
also
use
slope
comparison
test
compar
trend
trend
cytokin
accord
surviv
differ
trend
trend
cytokin
signific
p
close
zero
valu
estim
signific
relationship
trend
trend
cytokin
pvalu
consid
statist
signific
statist
softwar
sa
version
sa
institut
inc
cari
nc
use
analys
clinic
characterist
children
studi
shown
tabl
mean
age
patient
year
children
male
twelv
children
weight
percentil
age
sex
admiss
common
symptom
cough
tachypnea
fever
ratio
arteri
oxygen
partial
pressur
inspir
oxygen
fraction
pao
fio
admiss
nonsurvivor
higher
survivor
although
differ
group
statist
signific
admiss
peripher
blood
leukocyt
count
absolut
neutrophil
count
nonsurvivor
higher
survivor
p
p
respect
one
child
respiratori
viru
detect
nasopharyng
aspir
patient
bacteria
detect
sputum
blood
cultur
hospit
stay
patient
requir
supplement
oxygen
nonsurvivor
receiv
mechan
ventil
survivor
receiv
extracorpor
membran
oxygen
ecmo
steroid
therapi
use
patient
hydroxychloroquin
cyclophosphamid
administ
children
initi
followup
high
resolut
ct
score
groundglass
attenu
septal
thicken
bronchiectasi
sum
three
find
shown
tabl
chang
groundglass
attenu
septal
thicken
sum
score
initi
followup
greater
nonsurvivor
survivor
p
p
p
respect
wherea
air
leak
syndrom
initi
hrct
differ
group
find
common
followup
hrct
nonsurvivor
survivor
p
patholog
characterist
bronchiolar
destruct
peribronchiolar
inflamm
fibrosi
accompani
predominantli
centrilobular
destruct
lesion
diffus
alveolar
damag
gener
consist
previou
report
addit
type
ii
pneumocyt
hyperplasia
found
frequent
patient
patholog
find
differ
significantli
survivor
nonsurvivor
score
interstiti
intraalveolar
foami
macrophag
interstiti
intraalveolar
foami
macrophag
score
higher
nonsurvivor
p
tabl
score
bronchiolar
peribronchiolar
destruct
type
ii
pneumocyt
hyperplasia
intraalveolar
fibrin
exud
alveolar
inflammatori
cell
infiltr
alveolar
fibrosi
differ
survivor
nonsurvivor
frequenc
centrilobular
destruct
also
differ
group
serial
chang
cytokin
periostin
vegf
rant
gmcsf
shown
accord
surviv
figur
appendix
valu
survivor
maintain
approxim
pgml
admiss
discharg
wherea
valu
nonsurvivor
eventu
decreas
pgml
estim
slope
nonsurvivor
signific
differ
slope
found
survivor
p
tabl
differ
survivor
nonsurvivor
note
trend
serial
valu
cytokin
appendix
slope
cytokin
also
differ
significantli
group
tabl
compar
trend
trend
cytokin
accord
surviv
slope
comparison
analysi
slope
periostin
vegf
show
similar
trend
slope
gmcsf
show
opposit
trend
slope
nonsurviv
group
surviv
group
slope
similar
trend
slope
supplementari
tabl
sinc
nonsurvivor
eventu
fell
pgml
compar
serial
chang
clinic
cours
nonsurvivor
appendix
except
three
children
nonsurvivor
point
abruptli
decreas
shown
red
line
appendix
among
seven
nonsurvivor
abrupt
decreas
four
transfer
intens
care
unit
icu
manag
increas
ventil
set
eg
increas
posit
endexpiratori
pressur
peep
inspir
oxygen
fraction
fio
three
patient
initi
ecmo
around
time
abruptli
fell
three
patient
demonstr
abrupt
decreas
shown
blue
line
appendix
last
sampl
obtain
prior
worsen
respiratori
failur
exemplifi
increas
ventil
set
initi
ecmo
shown
figur
pao
fio
ratio
correl
well
pearson
correl
coeffici
r
p
sinc
valu
pao
fio
ratio
check
serial
children
adjust
analysi
serial
valu
patient
use
gener
linear
mix
model
adjust
model
pao
fio
ratio
correl
adjust
r
adjust
p
sinc
report
restor
deplet
vegf
secret
acut
lung
injuri
review
serial
chang
vegf
relat
seven
nonsurvivor
show
abrupt
decreas
depict
figur
vegf
decreas
time
fall
nonsurvivor
studi
suggest
maintain
elev
predict
eventu
improv
excess
pulmonari
inflamm
favor
outcom
hdchild
contrast
abrupt
decreas
elev
associ
decreas
vegf
reflect
worsen
respiratori
function
find
suggest
may
play
key
role
repair
damag
lung
control
excess
inflamm
acut
lung
injuri
rather
function
promot
progress
irrevers
fatal
fibrosi
involv
lung
develop
inflamm
injuryrel
fibrosi
repair
ild
especi
idiopath
pulmonari
fibrosi
ipf
usual
consid
poor
prognost
factor
induc
pulmonari
fibrosi
stimul
fibrogen
cytokin
endothelialmesenchym
transit
likewis
consid
potenti
therapeut
target
recent
report
inhibit
autophagosom
activ
thu
lead
pulmonari
fibrosi
lung
injuri
model
convers
also
import
develop
immatur
lung
neonat
excess
may
induc
bronchopulmonari
dysplasia
bpd
may
inhibit
alveolar
extrem
prematur
lung
specif
role
therefor
appear
tightli
control
result
appropri
amount
activ
correct
time
place
anim
model
hyperox
lung
injuri
repres
acut
lung
injuri
report
promot
repair
damag
lung
improv
surviv
also
repair
damag
deoxyribonucl
acid
increas
fibronectin
secret
acceler
closur
monolay
hyperox
cell
subject
scratch
wound
also
report
play
key
role
inhibit
excess
pulmonari
inflamm
hdchild
studi
role
seem
complex
relat
repair
damag
lung
control
sever
inflamm
promot
pulmonari
fibrosi
nonsurvivor
abrupt
decreas
correl
well
clinic
deterior
respiratori
function
exemplifi
event
increas
ventil
set
eg
high
peep
appli
ecmo
support
impend
sever
respiratori
failur
addit
pao
fio
wide
recogn
clinic
index
lung
injuri
tend
correl
posit
howev
correl
signific
statist
adjust
sever
measur
one
subject
consid
inevit
small
number
subject
irregular
sampl
time
interv
fatal
clinic
cours
diseas
seem
reason
consid
strict
statist
analysi
result
correl
chang
clinic
sever
respiratori
failur
lung
oxygen
index
may
provid
addit
indirect
evid
role
repair
damag
lung
control
excess
inflamm
vegf
function
promot
angiogenesi
increas
vascular
permeabl
identifi
reliabl
index
ipf
reflect
degre
lung
fibrosi
radiolog
imag
sever
diseas
paradox
vegf
also
suggest
possibl
therapeut
agent
role
stimul
growth
inhibit
apoptosi
alveolar
epitheli
cell
prematur
children
vegf
report
elev
compensatori
mechan
sever
respiratori
distress
proceed
bpd
vegf
like
therebi
exhibit
paradox
role
lung
injuri
patient
seem
function
repair
damag
lung
studi
likewis
provid
evid
human
support
result
anim
studi
restor
deplet
vegf
repair
acut
lung
injuri
potent
proinflammatori
cytokin
increas
patient
ipf
suggest
possibl
therapeut
target
evalu
largescal
phase
studi
anti
ipf
inflammatori
fibrot
cytokin
rant
dramat
increas
mous
model
ddac
compon
humidifi
disinfect
inject
trachea
increas
suscept
infect
host
immun
modul
relat
tolllik
receptor
tlr
periostin
gmcsf
report
import
factor
pulmonari
fibrosi
cytokin
increas
patient
hdchild
serial
chang
cytokin
relat
whether
patient
survivor
nonsurvivor
recent
nationwid
intervent
studi
hdchild
korea
identifi
use
clinic
prognost
marker
clinic
indic
radiolog
patholog
laboratori
find
current
studi
small
differ
clinic
indic
note
survivor
nonsurvivor
nonsurvivor
like
persist
air
leak
syndrom
extens
groundglass
attenu
septal
thicken
followup
ct
show
potenti
possibl
serial
ct
find
prognost
tool
higher
neutrophil
count
laboratori
test
greater
number
macrophag
patholog
find
groundglass
attenu
increas
neutrophil
count
increas
macrophag
reflect
inflamm
fibrosi
prognosi
ild
gener
close
associ
sever
pulmonari
fibrosi
sever
inflamm
fibrosi
usual
irrevers
wherea
inflamm
tend
revers
consid
clinic
find
nonsurvivor
prognosi
hdchild
seem
close
relat
excess
inflamm
fibrosi
well
control
excess
inflamm
seem
key
factor
determin
surviv
hdchild
children
vulner
lung
injuri
follow
exposur
toxic
materi
adult
time
repair
regener
damag
lung
may
fig
correl
transform
growth
factor
beta
ratio
arteri
oxygen
partial
pressur
inspir
oxygen
fraction
pao
fio
pao
fio
ratio
well
correl
r
p
adjust
model
consid
serial
valu
patient
pao
fio
ratio
correl
adjust
r
adjust
p
fig
serial
chang
transform
growth
factor
beta
vascular
endotheli
growth
factor
vegf
hospit
seven
nonsurvivor
vegf
decreas
time
decreas
nonsurvivor
abrupt
fall
promin
children
alveolar
persist
puberti
although
mostli
complet
month
age
sinc
children
studi
young
mean
age
year
old
seem
reason
excess
inflamm
follow
control
inflamm
repair
damag
lung
import
fibrosi
predict
prognosi
also
twelv
children
underweight
studi
seem
reflect
individu
function
deterior
increas
diseas
suscept
malnutrit
strength
limit
studi
might
consid
studi
provid
meaning
inform
role
control
inflamm
repair
acut
lung
injuri
human
especi
children
furthermor
subject
young
children
usual
difficult
includ
research
studi
studi
particularli
import
one
consid
increas
concern
recent
year
chemic
terror
studi
acut
lung
injuri
due
toxic
inhal
provid
inform
pathophysiolog
relat
therapeut
consider
prognost
factor
determin
analyz
serial
chang
cytokin
instead
singl
data
import
limit
limit
number
patient
analyz
blood
sampl
without
lung
tissu
exud
inevit
clinic
cours
hdchild
sever
aggress
unpredict
small
number
subject
plu
irregular
sampl
substanti
quantiti
miss
cytokin
data
made
statist
analysi
difficult
although
gener
mix
model
call
spaghetti
plot
use
help
overcom
also
could
reli
interview
parent
whether
humidifi
disinfect
expos
children
limit
studi
could
defin
clear
caus
effect
relationship
reevalu
welldesign
anim
model
conclus
studi
confirm
possibl
role
repair
damag
lung
control
vigor
inflamm
acut
lung
injuri
associ
unexpect
exposur
humidifi
disinfect
young
children
also
suggest
repair
mechan
could
promin
young
children
whose
lung
still
activ
grow
develop
adult
studi
involv
vitro
investig
vivo
anim
model
requir
directli
confirm
mechan
